Page last updated: 2024-11-03

promethazine and 2019 Novel Coronavirus Disease

promethazine has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Pillaiyar, T1
Wendt, LL1
Manickam, M1
Easwaran, M1
Zhu, M1
Hu, K1
Zhu, Z1

Reviews

1 review available for promethazine and 2019 Novel Coronavirus Disease

ArticleYear
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
    Medicinal research reviews, 2021, Volume: 41, Issue:1

    Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans

2021

Other Studies

1 other study available for promethazine and 2019 Novel Coronavirus Disease

ArticleYear
Use of convalescent plasma in COVID-19 patients in China.
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2020, Volume: 27, Issue:3

    Topics: Antibodies, Viral; Betacoronavirus; China; Combined Modality Therapy; Convalescence; Coronavirus Inf

2020